Provided by Tiger Fintech (Singapore) Pte. Ltd.

Hologic

61.47
+0.46000.75%
Post-market: 61.470.00000.00%18:15 EDT
Volume:7.42M
Turnover:455.19M
Market Cap:13.79B
PE:19.48
High:61.49
Open:60.98
Low:60.40
Close:61.01
Loading ...

Company Profile

Company Name:
Hologic
Exchange:
NASDAQ
Establishment Date:
1985
Employees:
7063
Office Location:
250 Campus Drive,Marlborough,Massachusetts,United States
Zip Code:
01752
Fax:
- -
Introduction:
Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment worldwide. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginosis and candida vaginitis assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays to detect SARS-CoV-2; ThinPrep System for cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. The company also offers breast cancer care solutions in the areas of radiology, breast surgery, pathology, and treatment, such as 3D digital mammography systems, image analytics software, reading workstations, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, and specimen radiology solutions; and breast conserving surgery products. In addition, it provides MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids and polyps in the uterus; NovaSure Endometrial Ablation System to treat abnormal uterine bleeding; Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures; Acessa ProVu system to treat various fibroids; and CoolSeal portfolio, such as bipolar vessel sealing devices. Further, it offers Horizon DXA, a dual energy X-ray system; and Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. It sells its products through direct sales, service forces, independent distributors, and sales representatives. The company was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.

Directors

Name
Position
Stephen P. MacMillan
Chairman, President and Chief Executive Officer
Amy M. Wendell
Director
Charles J. Dockendorff
Director
Christiana Stamoulis
Director
Ludwig N. Hantson
Director
Martin Madaus
Director
Nanaz Mohtashami
Director
Stacey D. Stewart
Director

Shareholders

Name
Position
Stephen P. MacMillan
Chairman, President and Chief Executive Officer
Essex D. Mitchell
Chief Operating Officer
Diana De Walt
Senior Vice President, Human Resources
Karleen M. Oberton
Chief Financial Officer
Brandon Schnittker
Division President, GYN Surgical Solutions
Jan Verstreken
Group President, International
Jennifer M. Schneiders
President, Diagnostic Solutions
John M. Griffin
General Counsel
Mark Horvath
Division President, Breast and Skeletal Health Solutions